Skip to main content
Top

International Journal of Hematology

Issue 1/2017

Including PIH Articles on Epigenetics in hematological malignancies

Content (18 Articles)

Editorial

Leaving IJH: joining to fly

Toshio Kitamura, Akifumi Takaori-Kondo

Images in Hematology

Chronic NK lymphocytosis identified by a distinct immunophenotypic pattern

Hae Tha Mya, Yeh Ching Linn, Lay Cheng Lim, Heng Joo Ng

Progress in Hematology

Epigenetic dysregulation in hematological malignancies

Atsushi Iwama

Progress in Hematology

SET/MLL family proteins in hematopoiesis and leukemia

Weiwei Yang, Patricia Ernst

Progress in Hematology

Dysregulation of TET2 in hematologic malignancies

Shigeru Chiba

Progress in Hematology

Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies

Goro Sashida, Atsushi Iwama

Progress in Hematology

The role of mutations in the cohesin complex in acute myeloid leukemia

Claire Mazumdar, Ravindra Majeti

Original Article

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia

Julie Waisbren, Shira Dinner, Jessica Altman, Olga Frankfurt, Irena Helenowski, Juehua Gao, Brandon J. McMahon, Brady L. Stein

Original Article

Pediatric thromboembolism: a national survey in Japan

Akira Ishiguro, Chibueze Chioma Ezinne, Nobuaki Michihata, Hisaya Nakadate, Atsushi Manabe, Masashi Taki, Midori Shima

Original Article

Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan

Katsuto Takenaka, Kazuya Shimoda, Naoyuki Uchida, Taizo Shimomura, Koji Nagafuji, Tadakazu Kondo, Hirohiko Shibayama, Takehiko Mori, Kensuke Usuki, Taichi Azuma, Yutaka Tsutsumi, Junji Tanaka, Hitomi Dairaku, Keitaro Matsuo, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Koichi Akashi

Original Article

Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study

A. M. Yesilova, S. Yavuzer, H. Yavuzer, M. Cengiz, I. D. Toprak, E. Hanedar, M. C. Ar, Z. Baslar

Original Article

A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia

Kotaro Miyao, Masashi Sawa, Mio Kurata, Ritsuro Suzuki, Reona Sakemura, Toshiyasu Sakai, Tomonori Kato, Satomi Sahashi, Natsuko Tsushita, Yukiyasu Ozawa, Motohiro Tsuzuki, Akio Kohno, Tatsuya Adachi, Keisuke Watanabe, Kaneyuki Ohbayashi, Yuichiro Inagaki, Yoshiko Atsuta, Nobuhiko Emi

Original Article

A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia

Takahiro Tanahashi, Nodoka Sekiguchi, Kazuyuki Matsuda, Akihiro Matsumoto, Toshiro Ito, Hideyuki Nakazawa, Fumihiro Ishida

Original Article

Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation

Toshihiro Miyamoto, Shuichiro Takashima, Koji Kato, Ken Takase, Goichi Yoshimoto, Shuro Yoshida, Hideho Henzan, Koichi Osaki, Tomohiko Kamimura, Hiromi Iwasaki, Tetsuya Eto, Takanori Teshima, Koji Nagafuji, Koichi Akashi

Case Report

Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury

Reiko Watanabe, Takayuki Tabayashi, Tatsuki Tomikawa, Morihiko Sagawa, Tomoe Anan-Nemoto, Yuta Kimura, Yasuyuki Takahashi, Michihide Tokuhira, Satoshi Otaki, Hidenori Oi, Makoto Sawano, Satoshi Sugiyama, Masahiro Kizaki

Case Report

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

Valentina Marchica, Fabrizio Accardi, Paola Storti, Cristina Mancini, Eugenia Martella, Benedetta Dalla Palma, Marina Bolzoni, Katia Todoerti, Magda Marcatti, Chiara Schifano, Sabrina Bonomini, Gabriella Sammarelli, Antonino Neri, Maurilio Ponzoni, Franco Aversa, Nicola Giuliani

Erratum

Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden

Tadahiko Igarashi, Michinori Ogura, Kuniaki Itoh, Masafumi Taniwaki, Kiyoshi Ando, Yoshiaki Kuroda, Kazuhito Yamamoto, Naokuni Uike, Akihiro Tomita, Hirokazu Nagai, Mitsutoshi Kurosawa, Shigeo Mori, Shigeru Nawano, Takashi Terauchi, Yasuo Ohashi, Kensei Tobinai

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine